Contributing scientists share their thoughts around the field of chemistry, focussing on enzyme activity assays for disease diagnosis, novel drug development validation and nanoparticles.
Thomas Münzel MD, Andreas Daiber PhD, Ulrich Pöschl PhD and Jos Lelieveld PhD discuss the link between air pollution and cardiovascular disease in Europe.
Cardiovascular diseases are on the rise, but so is confusion as to how to prevent them. Shaun Ingram, MD of Cardiac Science takes a look at the data, shares his views and strikes a cautious note of optimism.
John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.
Here, Open Access Government explore how the National Eye Institute in the U.S is supporting vision research that encompasses visual impairment diseases of people of all ages.
Makoto Suematsu, President of the Japan Agency for Medical Research and Development (AMED) details the challenges around global data sharing for orphan diseases.
In this interview, Chair of the ESC Digital Health Committee, Professor Martin Cowie, details the opportunities and challenges in the digital health era when it comes to the field of cardiovascular disease.
Prof Dr Regina Fluhrer, from the University of Augsburg, explains how intramembrane proteases have been implicated in the emergence of neurodegenerative diseases.